Laura Murillo Jaso
Hospital Clínico Universitario Lozano Blesa(ES)GEICAM – Spanish Breast Cancer Group(ES)
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, Breast Cancer Treatment Studies, Advanced Breast Cancer Therapies, HER2/EGFR in Cancer Research, Lymphoma Diagnosis and Treatment
Most-Cited Works
- → Management of patients with metastatic breast cancer(2011)16 cited
- → Prognostic and predictive value of ESR1 mutations in postmenopausal metastatic breast cancer (MBC) patients (pts) resistant to aromatase inhibitors (AI), treated with palbociclib (PAL) in combination with endocrine therapy (ET) or capecitabine (CAP) in the PEARL study.(2020)3 cited
- → Neoadjuvant chemotherapy based on dose-dense epirubicin (E) plus cyclophosphamide (C) followed by docetaxel (D) plus trastuzumab (T), DT plus carboplatin (CBDCA), or DT plus HER2 double blockade in HER2-positive breast cancer patients.(2015)
- → Elderly breast cancer patients treated with Nab-paclitaxel: Results in real clinical practice(2020)
- → Abstract P5-11-04: Anti-proliferative effect of oral metronomic vinorelbine (mVNB) in PAM50 Luminal/HER2-negative early breast cancer (SOLTI-1501 VENTANA): A randomized, three-arm, window-of-opportunity study(2019)
- Oxicodona en dolor oncológico: Experiencia clínica(2008)
- → Changing trends in HIV and cancer(2016)